Marcus Maurer Selected Research

Marcus Maurer Research Topics

Disease

89	Chronic Urticaria 02/2022 - 06/2008
68	Urticaria (Hives) 02/2022 - 01/2007
35	Hereditary Angioedemas 07/2022 - 04/2010
31	Angioedema 10/2021 - 06/2008
20	Hypersensitivity (Allergy) 01/2022 - 08/2003
19	Inflammation (Inflammations) 01/2021 - 12/2004
16	Pruritus (Itching) 01/2021 - 08/2006
15	Cold Urticaria 01/2022 - 03/2009
13	Chronic Inducible Urticaria 01/2022 - 01/2014
12	Asthma (Bronchial Asthma) 01/2021 - 03/2009
11	Atopic Dermatitis (Atopic Eczema) 01/2021 - 01/2010
9	Anaphylaxis (Anaphylactic Shock) 01/2022 - 10/2009
8	Allergic Rhinitis 01/2021 - 04/2010
7	Familial dermographism 01/2022 - 01/2011
7	Infections 01/2021 - 06/2007
6	Contact Dermatitis (Eczema, Contact) 07/2021 - 08/2003
5	COVID-19 12/2021 - 01/2020
5	Skin Diseases (Skin Disease) 07/2021 - 12/2016
4	Prurigo 01/2022 - 03/2013
4	Solar Urticaria 07/2018 - 01/2011
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 01/2015
3	Schnitzler Syndrome 01/2021 - 04/2017
3	Vasculitis (Vasculitides) 01/2020 - 09/2013
3	Neoplasms (Cancer) 01/2020 - 03/2014
3	Necrosis 01/2017 - 01/2012
2	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 07/2021
2	Eczema 07/2021 - 12/2014
2	Edema (Dropsy) 04/2021 - 09/2010
2	Nasal Polyps (Nasal Polyp) 01/2021 - 01/2020
2	Rhinosinusitis 01/2020 - 07/2014
2	Neurogenic Inflammation 01/2019 - 04/2008
2	Hereditary Angioedema Types I and II 01/2019 - 11/2018
2	Mastocytosis 01/2018 - 12/2012
2	Rare Diseases (Rare Disease) 04/2017 - 12/2012
2	Alopecia (Baldness) 10/2016 - 06/2007

Drug/Important Bio-Agent (IBA)

62	Omalizumab (Xolair)FDA Link 01/2022 - 09/2010
37	Histamine Antagonists (Antihistamines)IBA 01/2022 - 03/2009
25	Immunoglobulin E (IgE)IBA 01/2022 - 07/2009
17	Cholinergic Agents (Cholinergics)IBA 01/2022 - 02/2014
15	CytokinesIBA 12/2021 - 08/2006
12	icatibantIBA 01/2019 - 04/2010
11	BradykininIBA 08/2021 - 04/2010
11	Histamine (Histamine Dihydrochloride)FDA Link 01/2020 - 06/2008
10	AllergensIBA 01/2022 - 08/2003
9	AutoantibodiesIBA 11/2021 - 04/2011
8	Immunoglobulin G (IgG)IBA 01/2022 - 04/2015
8	Biological ProductsIBA 01/2022 - 01/2017
8	anti-IgE antibodiesIBA 12/2019 - 07/2007
7	Monoclonal AntibodiesIBA 07/2022 - 01/2018
7	rupatadineIBA 12/2019 - 01/2010
6	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2022 - 09/2015
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2010
6	lanadelumabIBA 01/2022 - 11/2018
6	AntigensIBA 01/2021 - 01/2012
6	desloratadine (Aerius)FDA LinkGeneric 12/2019 - 03/2009
6	Peptide Hydrolases (Proteases)FDA Link 01/2018 - 08/2006
5	NeuropeptidesIBA 01/2022 - 08/2006
5	AntibodiesIBA 07/2021 - 07/2011
5	Plasma KallikreinIBA 06/2021 - 01/2016
5	Substance PIBA 01/2021 - 06/2007
5	Interleukin-6 (Interleukin 6)IBA 01/2020 - 01/2012
5	Non-Sedating Histamine H1 Antagonists (Histamine H1 Antagonists, Non Sedating)IBA 01/2019 - 10/2008
4	Tryptases (Tryptase)IBA 09/2022 - 10/2009
4	ligelizumabIBA 02/2022 - 10/2019
4	Pharmaceutical PreparationsIBA 01/2021 - 08/2012
4	ChemokinesIBA 01/2015 - 08/2007
3	berotralstatIBA 06/2021 - 01/2018
3	Immunoglobulin A (IgA)IBA 01/2021 - 12/2020
3	dupilumabIBA 01/2021 - 01/2019
3	Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA 07/2020 - 01/2018
3	canakinumab FDA Link 01/2020 - 09/2013
3	fexofenadine (Allegra)FDA LinkGeneric 12/2019 - 05/2013
3	levocetirizine FDA LinkGeneric 12/2019 - 05/2013
3	C-Reactive ProteinIBA 01/2018 - 05/2013
3	Bradykinin B2 ReceptorIBA 09/2015 - 04/2010
3	Interleukin-33IBA 01/2015 - 04/2012
3	Chymases (Chymase)IBA 02/2014 - 08/2007
3	Interleukin-10 (Interleukin 10)IBA 01/2012 - 08/2003
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2007 - 01/2003
2	AndrogensIBA 01/2022 - 02/2011
2	Iodide Peroxidase (Deiodinase)IBA 01/2022 - 04/2011
2	fenebrutinibIBA 01/2022 - 11/2021
2	Antiviral Agents (Antivirals)IBA 12/2021 - 01/2021
2	InflammasomesIBA 07/2021 - 10/2012
2	CryoglobulinsIBA 01/2021 - 01/2021
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2021 - 01/2021
2	Peroxidase (Myeloperoxidase)IBA 01/2021 - 01/2019
2	cold agglutininsIBA 01/2021 - 01/2021
2	mepolizumabIBA 07/2020 - 04/2018
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2020 - 12/2013
2	Biomarkers (Surrogate Marker)IBA 12/2019 - 10/2008
2	Histamine H1 Receptors (Histamine H1 Receptor)IBA 12/2019 - 01/2011
2	Codeine (Codeine Phosphate)FDA LinkGeneric 07/2019 - 01/2012
2	Interleukin-1 (Interleukin 1)IBA 01/2019 - 10/2012
2	AutoantigensIBA 01/2018 - 07/2011
2	Rituximab (Mabthera)FDA Link 08/2017 - 01/2017
2	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 03/2017 - 11/2016
2	montelukast (Singulair)FDA Link 02/2017 - 09/2015

Therapy/Procedure

40	Therapeutics 03/2022 - 01/2007
3	Injections 01/2014 - 09/2006